Dopamine Transporter Mutants with Cocaine Resistance and Normal Dopamine Uptake Provide Targets for Cocaine Antagonism
Authors:
- 1 April 2002
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 61 (4) , 885-891
Abstract
Cocaine9s blockade of dopamine reuptake by brain dopamine transporters (DAT) is a central feature of current understanding of cocaine reward and addiction. Empirical screening of small-molecule chemical libraries has thus far failed to provide successful cocaine blockers that allow dopamine reuptake in the presence of cocaine and provide cocaine “antagonism”. We have approached this problem by assessing expression, dopamine uptake, and cocaine analog affinities of 56 DAT mutants in residues located in or near transmembrane domains likely to play significant roles in cocaine recognition and dopamine uptake. A phenylalanine-to-alanine mutant in putative DAT transmembrane domain 3, F154A, retains normal dopamine uptake, lowers cocaine affinity 10-fold, and reduces cocaine stereospecificity. Such mutants provide windows into DAT structures that could serve as targets for selective cocaine blockers and document how combined strategies of mutagenesis and small molecule screening may improve our abilities to identify and design compounds with such selective properties.Keywords
This publication has 25 references indexed in Scilit:
- The role of conserved tryptophan and acidic residues in the human dopamine transporter as characterized by site‐directed mutagenesisJournal of Neurochemistry, 2001
- Novel Conformationally Constrained Tropane Analogues by 6-endo-trig Radical Cyclization and Stille Coupling − Switch of Activity toward the Serotonin and/or Norepinephrine TransporterJournal of Medicinal Chemistry, 2000
- Permeation and gating residues in serotonin transporterProceedings of the National Academy of Sciences, 2000
- Synthesis and Pharmacology of Site-Specific Cocaine Abuse Treatment Agents: 2-Substituted-6-amino-5-phenylbicyclo[2.2.2]octanesJournal of Medicinal Chemistry, 1999
- (−)-3β-Substituted Ecgonine Methyl Esters as Inhibitors for Cocaine Binding and Dopamine UptakeJournal of Medicinal Chemistry, 1998
- The Third Transmembrane Domain of the Serotonin Transporter Contains Residues Associated with Substrate and Cocaine BindingJournal of Biological Chemistry, 1997
- Dopamine transporter immunoreactivity in rat brainJournal of Comparative Neurology, 1995
- Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium.Proceedings of the National Academy of Sciences, 1994
- Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding.Proceedings of the National Academy of Sciences, 1992
- Cocaine receptor: biochemical characterization and structure-activity relationships of cocaine analogs at the dopamine transporterJournal of Medicinal Chemistry, 1992